You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 2, 2026
Sale
Calculated transaction value
$163.43K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 1, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$512.7
Sep 1, 2026
First close after public filing
$490.24
Sep 3, 2026
30-day return after filing
+10.5%
Through Oct 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 320 shares @ $510.72
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000133
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.17M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 1, 2026 | $1.29M |
| United Therapeutics Corp UTHR Current | Sale | Sep 1, 2026 | $163.43K |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $422.36K |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $888.72K |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $1.78M |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $834.27K |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $758.05K |
| United Therapeutics Corp UTHR | Sale | Sep 1, 2026 | $41.33K |
| United Therapeutics Corp UTHR | Exercise | Sep 1, 2026 | $0 |